首页 › 基金 › ORBIMED ADVISORS LLC › QTTB
ORBIMED ADVISORS LLC 对 QTTB 的持仓历史
Q32 Bio Inc · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 QTTB(Q32 Bio Inc)4,127,987 股,市值约 US$52.6M,约占其申报组合的 1.06%,在其申报持仓中市值排名第 30 位。 ORBIMED ADVISORS LLC 最近 10 个申报季度中有 10 个季度披露了 QTTB 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 QTTB 的持仓演变
ORBIMED ADVISORS LLC 于 Q1 2024 首次披露 QTTB 持仓:2,252,987 股(约 US$38.4M)。 该持仓在 Q3 2024 达到峰值 2,252,987 股,市值约 US$100.5M。 在 10 次申报中,ORBIMED ADVISORS LLC 1 次增持、0 次减持、8 次保持不变。 最近一期申报(Q2 2026)显示持股 4,127,987 股、市值约 US$52.6M,环比增持 1,875,000 股。。 持仓曾出现大幅变动:Q2 2026 增持约 83% (随后一个季度股价下跌 35%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 2.25M | $38.39M | 新进 |
| Q2 2024 | 2.25M | $40.44M | 持有 |
| Q3 2024 | 2.25M | $100.53M | 持有 |
| Q4 2024 | 2.25M | $7.75M | 持有 |
| Q1 2025 | 2.25M | $3.72M | 持有 |
| Q2 2025 | 2.25M | $3.36M | 持有 |
| Q3 2025 | 2.25M | $4.46M | 持有 |
| Q4 2025 | 2.25M | $7.48M | 持有 |
| Q1 2026 | 2.25M | $14.46M | 持有 |
| Q2 2026 | 4.13M | $52.59M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 QTTB 与 13F 数据
QTTB(Q32 Bio Inc)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 QTTB,申报仓位最大的包括:Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M), BVF INC/IL (US$29.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 QTTB 的基金
- Boxer Capital Management, LLC 3.15M 股 · $40.12M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M 股 · $34.62M · Q2 2026
- BVF INC/IL 2.35M 股 · $29.94M · Q2 2026
- Opaleye Management Inc. 931.00K 股 · $11.86M · Q2 2026
- Logos Global Management LP 800.00K 股 · $10.19M · Q2 2026
- Sanofi 244.08K 股 · $3.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K 股 · $2.75M · Q2 2026
- Carlyle Group Inc. 60.36K 股 · $769.02K · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held QTTB?
ORBIMED ADVISORS LLC has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is ORBIMED ADVISORS LLC's current position in QTTB?
As of Q2 2026, ORBIMED ADVISORS LLC holds 4.13M shares of QTTB (Q32 Bio Inc), valued at $52.59M, representing 1.06% of its reported portfolio and ranking #30.
Has ORBIMED ADVISORS LLC been buying or selling QTTB?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in QTTB. The position peaked in Q3 2024 at 2.25M shares.
Which other funds hold QTTB?
Other major institutional holders of QTTB include Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, BVF INC/IL, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.